-- Preview Email Newsletter
| Journals Psychology Newsletter for 2026-02-11 ( 4 items ) |
|
AI for Soldiers, Movies, and Children: USC Engineer Elected to National Academy (10)
LOS ANGELES, California, Feb. 10 -- The University of Southern California Viterbi School of Engineering posted the following news:
* * *
AI for Soldiers, Movies, and Children: USC Engineer Elected to National Academy
*
From teaching machines to understand human emotion to bringing an engineering lens to understand and support human mental health and wellbeing, Shrikanth "Shri" Narayanan has spent three decades at the intersection of engineering and humanity. The professor at the Viterbi Scho more PR
Cornell researchers win prize for insight into conspiracy belief (10)
ITHACA, New York, Feb. 10 -- Cornell University posted the following news:
* * *
Cornell researchers win prize for insight into conspiracy belief
*
An article about AI combatting conspiracy theories, co-authored by Cornell psychology researchers Gordon Pennycook and David Rand with a collaborator, has won the 2026 Newcomb Cleveland Prize from the American Association for the Advancement of Science (AAAS). The association's oldest award, the prize is given to the authors of an outstanding res more PR
Griffith University: Men Resort to Buying Underground Testosterone to Bridge Access Gap (10)
GOLD COAST, Australia, Feb. 10 (TNSjou) -- Griffith University issued the following news:
* * *
Men resort to buying underground testosterone to bridge access gap
Some men are resorting to obtaining testosterone replacement therapy (TRT) from underground sources due to significant barriers to accessing the therapy through formal medical channels, according to new Griffith University research.
PhD Candidate Ben Bonenti from Griffith University's School of Applied Psychology explored the exper more PR
Rutgers: Why People Won't Quit a Weight Loss Drug - Even When It Makes Them Feel Sick (10)
NEW BRUNSWICK, New Jersey, Feb. 11 (TNSjou) -- Rutgers University issued the following news:
* * *
Why People Won't Quit a Weight Loss Drug - Even When It Makes Them Feel Sick
Rutgers Health research sheds light on why people using the anti-obesity medication semaglutide say the results matter more than the side effects
By Nakaysha Gonzalez
Patients who use semaglutide for weight loss, like Ozempic, are more likely to continue the medication if they perceive it as effective, even when facin more PR
|
